Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ainara Meler

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cells|February 28, 2020
MYC's Fine Line Between B Cell Development and MalignancyOriol de Barrios, Ainara Meler, Maribel Parra
Nucleic Acids Research|July 29, 2022
The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte developmentAlba Azagra, Ainara Meler, Oriol de Barrios, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosisAinara Meler, Mar Gusi-Vives, Oriol de Barrios, et al.
Leukemia|December 2, 2020
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemiaOriol de Barrios, Alexandros Galaras, Juan L Trincado, et al.
Biomarker Research|July 29, 2025
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemiaOriol de Barrios, Ingrid Ocón-Gabarró, Mar Gusi-Vives, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cells|February 28, 2020
MYC's Fine Line Between B Cell Development and MalignancyOriol de Barrios, Ainara Meler, Maribel Parra
Nucleic Acids Research|July 29, 2022
The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte developmentAlba Azagra, Ainara Meler, Oriol de Barrios, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosisAinara Meler, Mar Gusi-Vives, Oriol de Barrios, et al.
Leukemia|December 2, 2020
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemiaOriol de Barrios, Alexandros Galaras, Juan L Trincado, et al.
Biomarker Research|July 29, 2025
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemiaOriol de Barrios, Ingrid Ocón-Gabarró, Mar Gusi-Vives, et al.
Pageof 1